This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
₹1.15
Share price
-33.50%
Change (1 day)
-98.88%
Change (1 year)
Categories
Market capitalization of Athersys (ATHX)
Last known market cap: ₹71.12 Million
On March 12, 2024 Athersys had a market cap of ₹71.12 Million. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Athersys from 2007 to 2024
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2024 | ₹71.47 M | -30.44% |
| 2023 | ₹0.10 B | -91.41% |
| 2022 | ₹1.19 B | -92.43% |
| 2021 | ₹15.80 B | -38.86% |
| 2020 | ₹25.84 B | 84.43% |
| 2019 | ₹14.01 B | -3.53% |
| 2018 | ₹14.52 B | 6.06% |
| 2017 | ₹13.69 B | 53.57% |
| 2016 | ₹8.92 B | 55.67% |
| 2015 | ₹5.73 B | -26.36% |
| 2014 | ₹7.78 B | -28.72% |
| 2013 | ₹10.91 B | 254.52% |
| 2012 | ₹3.07 B | 43.16% |
| 2011 | ₹2.15 B | 2.66% |
| 2010 | ₹2.09 B | -42.24% |
| 2009 | ₹3.62 B | 785.85% |
| 2008 | ₹0.40 B | -88.77% |
| 2007 | ₹3.64 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | ₹12.888 T | 18,122,003.71% | 🇺🇸 USA |
 | ₹11.095 T | 15,601,096.85% | 🇺🇸 USA |
 | ₹8.319 T | 11,697,530.48% | 🇺🇸 USA |
 | ₹898.31 B | 1,262,962.95% | 🇺🇸 USA |
 | ₹31.747 T | 44,638,517.53% | 🇺🇸 USA |
 | ₹225.73 B | 317,297.07% | 🇺🇸 USA |
 | ₹526.27 B | 739,854.52% | 🇺🇸 USA |
 | ₹17.772 T | 24,988,538.56% | 🇺🇸 USA |
 | ₹10.907 T | 15,336,096.63% | 🇫🇷 France |